
USFDA APPLICATION NUMBER - 22301 / DOSAGE - CAPSULE, EXTENDED RELEASE;ORAL - 375MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| MESALAMINE(UNII: 4Q81I59GXC) (MESALAMINE - UNII:4Q81I59GXC) | MESALAMINE | 375mg |
Inactive Ingredients
| Ingredient Name | Physicians Total Care, Inc. | Salix Pharmaceuticals, Inc. |
|---|---|---|
| ANHYDROUS CITRIC ACID(XF417D3PSL) | ||
| ASPARTAME(Z0H242BBR1) | ||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | ||
| CROSPOVIDONE(2S7830E561) | ||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | ||
| HYPROMELLOSES(3NXW29V3WO) | ||
| MAGNESIUM STEARATE(70097M6I30) | ||
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1)(74G4R6TH13) | ||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | ||
| POVIDONE(FZ989GH94E) | ||
| SILICON DIOXIDE(ETJ7Z6XBU4) | ||
| TALC(7SEV7J4R1U) | ||
| TITANIUM DIOXIDE(15FIX9V2JP) | ||
| TRIETHYL CITRATE(8Z96QXD6UM) |